Navigation Links
Stanford researchers discover molecular determinant of cell identity
Date:3/21/2011

STANFORD, Calif. If a big bunch of your brain cells suddenly went rogue and decided to become fat cells, it could cloud your decision-making capacity a bit. Fortunately, early in an organism's development, cells make firm and more-or-less permanent decisions about whether they will live their lives as, say, skin cells, brain cells or, well, fat cells.

Those decisions essentially boil down to which proteins, among all the possible candidates encoded in a cell's genes, the cell will tend to make under ordinary circumstances. But exactly how a cell chooses its default protein selections from an overwhelmingly diverse genetic menu is somewhat mysterious.

A new study from the Stanford University School of Medicine may help solve the mystery. The researchers discovered how a particular variety of the biomolecule RNA that had been thought to be largely irrelevant to cellular processes plays a dynamic regulatory role in protein selection. In unraveling this molecular mechanism, the study also offers enticing clues as to how certain cancers may arise.

Howard Chang, MD, PhD, associate professor of dermatology, is the senior author of the study, to be published online March 20 in Nature.

"All the cells in your body have the same genes, but they don't all make the same proteins," said Chang, MD, PhD, who is also a Howard Hughes Medical Institute Early Career Scientist. In this new study, Chang and his colleagues identified a novel action by a subset of RNA that reinforces cells' decisions about which combinations of their genes are to be active and which must stay silent.

RNA is a chemical lookalike of DNA the stuff our genes are made of that, according to standard textbooks, mainly functions as a messenger: a copy of a gene, made by a cell's gene-reading machinery, that can float away from the chromosomes where genes reside to other places in the cell where proteins are made. There the messenger-RNA molecule serves as an instruction manual for the production of proteins.

Scientists used to see RNA mostly as a stodgy servant of its kingly commander, DNA, in the protein-production process. But in recent decades scientists have learned of several ways RNA can influence the production of proteins besides merely conveying information from genes to a cell's protein-making apparatus.

In the Nature study, the researchers identified a novel regulatory role for a class of RNA molecules called lincRNA (for long intergenic noncoding RNA). A typical cell spawns as many as 10,000 distinct species of lincRNA molecules on a par with the number of conventional protein-coding genes but lincRNAs don't spell out recipes for making proteins. For years, many biochemists were skeptical that lincRNA played any important role in a cell and considered the molecules just mere "noise," perhaps vestigial protein-coding genes that had mutated to become nonfunctional. Chang's group has been instrumental in proving that lincRNAs can play a critical regulatory role: determining what proteins a cell produces and, thereby, what identity it assumes.

To do so, Chang and his associates turned to human fibroblasts, which are easily grown in culture. Fibroblasts are cells that lie just beneath the skin and secrete factors determining skin cells' local character. "You'll never see hair growing out of someone's palm," Chang said. The factors that fibroblasts secrete vary depending on where in the body they're located.

Remarkably, cultured fibroblasts from different parts of the body somehow remember their sense of where they belong, continuing to maintain characteristic patterns of genes that are "on" or "off" even over dozens of generations of cell division in a petri dish. "Why is that?" Chang asked.

A related question intrigued the study's first author, Kevin Wang, MD, PhD, an instructor of dermatology and a postdoctoral scholar in Chang's lab. "I was initially interested in conditions like psoriasis, a skin disease whose manifestations in the body are region-specific," he said. "Cells that have the same DNA, that look the same under a microscope what made them act differently?"

Chang has been using cultured fibroblasts as workhorse cells to help answer these questions. In a study published last year in Science, his group showed that one species of lincRNA, which he and his labmates had discovered and named HOTAIR, acts quite differently from your standard mRNA molecule: It contorts into a kind of adapter plug and then latches onto massive protein complexes, which have the ability to silence genes. Once hooked up to such complexes, HOTAIR shuttles them to particular spots along a chromosome "positional identity" genes. Defects in these genes, first identified in fruit flies, can result in bizarre outcomes such as a fly with legs growing out of its head, instead of antennae. Particular on/off patterns of a cell's positional-identity genes lead the cell to behave in a characteristic way (palm versus scalp, for example).

In a nutshell, HOTAIR locks cells' positional identities into place by marking key genes with the biochemical equivalent of "gone fishing" signs, so that they remain closed for business.

The new study, in contrast, demonstrates how another lincRNA, dubbed HOTTIP, grabs onto an opposing type of protein complex, which marks similar positional-identity genes as "open for business." The researchers observed that this complex wheels into action once HOTTIP links to it, and then biochemically fixes cell-position-appropriate genes in the "on" position.

An ability to act as a mute button for protein production has been demonstrated for other RNA types besides lincRNA. But, said Chang, HOTTIP is the first example of any RNA molecule that creates a memory of gene activation rather than silencing them. "When we experimentally impeded HOTTIP activity, fibroblasts that were supposed to express certain positional-identity genes didn't," he said.

Interestingly, the particular genes that HOTTIP caused to retain a switched-on status were fairly remote from one another along the stretch of chromosome where they reside. To learn more about how this works, Chang, Wang and their Stanford colleagues teamed up with a group at the University of Massachusetts Medical School, in Worcester, whose research focuses on the three-dimensional organization of genomes.

What they learned from this holds implications for how some cancers could get started. The investigators found that DNA can form complicated looping structures that bring genes distant from one another on a chromosome, or on entirely different chromosomes, physically close. This lets HOTTIP and the protein complex it's linked to efficiently mark appropriate genes as "open for business."

But it could also lead to things going awry, possibly triggering certain cancers. Biochemical interactions at close range among these ordinarily distant genes can cause their fusion or even an exchange in their positions and resulting faulty protein production characteristic of a number of cancers, Chang said.


'/>"/>

Contact: Bruce Goldman
goldmanb@stanford.edu
650-725-2106
Stanford University Medical Center
Source:Eurekalert

Related medicine news :

1. New gene regions identified that predispose people to heart attacks, Stanford scientists say
2. Evidence lacking for widespread use of costly antipsychotic drugs, says Stanford researcher
3. Stanford researchers first to turn normal cells into 3-D cancers in tissue culture dishes
4. Certain cancer therapies success depends on presence of immune cell, Stanford study shows in mice
5. Need a study break to refresh? Maybe not, say Stanford researchers
6. Stanford-led study disproves link between genetic variant, risk of coronary artery disease
7. Wider statin use could be cost-effective preventive measure, Stanford study finds
8. Preventive care poses dilemma for emergency departments, Stanford study finds
9. New treatment for severe aortic stenosis shown to save lives, Stanford researchers say
10. Arsenic shows promise as cancer treatment, Stanford study finds
11. Stanford Who's Who & Anthony Casimano Make Donation to Help Support National Organization, CancerCare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: